Caplin Point Laboratories Ltd - 524742 - Announcement under Regulation 30 (LODR)-Press Release / Media Release

Caplin Point Laboratories Ltd.

NSE: CAPLIPOINT | BSE: 524742 | ISIN: INE475E01026 | Industry: Pharmaceuticals
| Falling Comet

1929.6000 -27.40 (-1.40%)

NSE Aug 06, 2025 15:31 PM

26.94% Fall from 52W High

Volume: 118.3K

Caplin Point Laboratories Ltd.

14 May 2025

1929.60

-1.40%

Company Update

Caplin Point Laboratories Ltd - 524742 - Announcement under Regulation 30 (LODR)-Press Release / Media Release

BSE India

Press Release regarding receipt of USFDA Approval is attached herewith.

More from Caplin Point Laboratories Ltd.

Recommended

Market closes lower, Lupin's Q1 net profit surges 52.1% YoY to Rs 1,219 crore

Trendlyne Marketwatch | 06 Aug 2025, 03:56PM

Five stocks to buy from analysts this week - August 6, 2025

The Baseline | 06 Aug 2025, 10:55AM

Caplin Point Laboratories maintains export momentum, expands ambitions to new markets